GB201621737D0 - Compositions and methods of treatment - Google Patents

Compositions and methods of treatment

Info

Publication number
GB201621737D0
GB201621737D0 GBGB1621737.4A GB201621737A GB201621737D0 GB 201621737 D0 GB201621737 D0 GB 201621737D0 GB 201621737 A GB201621737 A GB 201621737A GB 201621737 D0 GB201621737 D0 GB 201621737D0
Authority
GB
United Kingdom
Prior art keywords
compositions
treatment
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1621737.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aberystwyth University
Original Assignee
Aberystwyth University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aberystwyth University filed Critical Aberystwyth University
Priority to GBGB1621737.4A priority Critical patent/GB201621737D0/en
Publication of GB201621737D0 publication Critical patent/GB201621737D0/en
Priority to PCT/GB2017/053847 priority patent/WO2018115877A2/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10Peptides having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/44Medicaments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/46Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404Biocides, antimicrobial agents, antiseptic agents
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/10Screening for compounds of potential therapeutic value involving cells
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
GBGB1621737.4A 2016-12-20 2016-12-20 Compositions and methods of treatment Ceased GB201621737D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1621737.4A GB201621737D0 (en) 2016-12-20 2016-12-20 Compositions and methods of treatment
PCT/GB2017/053847 WO2018115877A2 (en) 2016-12-20 2017-12-20 Compositions and methods of treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1621737.4A GB201621737D0 (en) 2016-12-20 2016-12-20 Compositions and methods of treatment

Publications (1)

Publication Number Publication Date
GB201621737D0 true GB201621737D0 (en) 2017-02-01

Family

ID=58284277

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1621737.4A Ceased GB201621737D0 (en) 2016-12-20 2016-12-20 Compositions and methods of treatment

Country Status (2)

Country Link
GB (1) GB201621737D0 (en)
WO (1) WO2018115877A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111387133B (en) * 2020-02-25 2021-04-16 中国农业大学 Method for establishing model for inhibiting mouse mastitis by using Klebsiella pneumoniae bacteriophage
IT202100007211A1 (en) * 2021-03-24 2022-09-24 Softmining S R L PEPTIDE WITH ANTIMICROBIAL ACTIVITY
IT202100007214A1 (en) * 2021-03-24 2022-09-24 Softmining S R L PEPTIDE WITH ANTIMICROBIAL ACTIVITY

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436703B1 (en) * 2000-03-31 2002-08-20 Hyseq, Inc. Nucleic acids and polypeptides

Also Published As

Publication number Publication date
WO2018115877A2 (en) 2018-06-28
WO2018115877A3 (en) 2018-08-02

Similar Documents

Publication Publication Date Title
GB2582482B (en) CASZ compositions and methods of use
HK1258205A1 (en) Compositions and methods for the treatment of hemoglobinopathies
IL258955A (en) Compositions and methods for treatment of cancer
GB2582100B (en) CAS12C Compositions and methods of use
HK1248531A1 (en) Immunomodulatory compositions and methods of use thereof
ZA201900960B (en) Methods and compositions for the treatment of cancer
ZA201906169B (en) Synthekine compositions and methods of use
HK1247789A1 (en) Compositions and methods for treatment of edema
HK1249515A1 (en) Methods and compositions for the prevention and treatment of hearing loss
ZA201902781B (en) Compositions and methods for the treatment of xerostomia
HK1255221A1 (en) Methods of treatment using cadotril compositions
HK1258502A1 (en) Compositions and methods for treatment of homocystinuria
ZA201808232B (en) Compositions and methods for the treatment of cancer
HK1252057A1 (en) Novel method of use and compositions
HK1250345A1 (en) Compositions comprising 15-oxo-epa or 15-oxo-dgla and methods of making and using same
IL259710A (en) Compositions and methods of treatment for mvid and related diseases
HK1245101A1 (en) Compositions comprising 15-hepe and methods of treating or preventing fibrosis using same
ZA201900984B (en) Methods and compositions for the treatment of warts
HK1255695A1 (en) Composition and methods for the treatment of blepharoptosis
GB201511799D0 (en) Composition and methods of treatment
GB2591422B (en) Maca compositions and methods of use
GB201621737D0 (en) Compositions and methods of treatment
HK1248527A1 (en) Dental compositions and methods of use
GB201605127D0 (en) Composition and methods of treatment
DK3313207T3 (en) Compositions and methods for the treatment of malnutrition

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)